What is the recommended oral (po) dose of hydralazine (direct vasodilator) for hypertension management on an as-needed (prn) basis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydralazine Oral (PO) Dosing for PRN Hypertension Management

For PRN (as-needed) management of hypertension, hydralazine should be dosed at 10-25 mg orally every 4-6 hours, with a maximum daily dose of 200 mg for most patients. 1

Initial Dosing and Titration

  • Start with 10 mg four times daily for the first 2-4 days, then increase to 25 mg four times daily for the remainder of the first week 1
  • For subsequent weeks, dosage may be increased to 50 mg four times daily if needed 1
  • Maintenance dosage should be adjusted to the lowest effective level 1
  • In resistant hypertension cases, up to 300 mg daily may be required, but this higher dose increases risk of adverse effects 1

PRN Administration Guidelines

  • Hydralazine is frequently prescribed as a PRN medication for acute blood pressure management in hospitalized patients 2
  • PRN oral hydralazine should generally be reserved for systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg (threshold for acute severe hypertension) 2
  • Caution is advised as studies show 36% of PRN administrations occur at lower thresholds than recommended 2

Pharmacokinetics and Dosing Frequency

  • Hydralazine has a relatively short plasma half-life but demonstrates prolonged antihypertensive effects 3
  • Despite its short half-life, hydralazine shows a multiexponential pattern of elimination with a prolonged terminal phase 3
  • For scheduled (non-PRN) dosing, twice-daily administration is generally sufficient for blood pressure control 4
  • Once-daily conventional hydralazine is not recommended as its hypotensive effect wanes at 24 hours 4

Special Considerations

  • Response to hydralazine varies based on acetylator status - slow acetylators experience greater hypotensive effects and more side effects 5
  • When using hydralazine PRN, monitor for excessive blood pressure reduction, especially when combined with other antihypertensive medications 1
  • Profound hypotensive episodes may occur when hydralazine is used concomitantly with other potent antihypertensives 1
  • Administration with food results in higher plasma levels 1

Combination Therapy

  • Lower dosage of hydralazine combined with a thiazide diuretic and/or beta blocker may be more effective with fewer side effects than high-dose hydralazine monotherapy 1
  • Combination with beta-blockers (such as propranolol) can mitigate reflex tachycardia and provide more stable blood pressure control 6
  • Hydralazine is classified as a direct vasodilator and is associated with sodium/water retention and reflex tachycardia; consider using with a diuretic 7

Cautions and Monitoring

  • Monitor for common side effects including headache, tachycardia, fluid retention, and lupus-like syndrome (particularly at higher doses) 7
  • Hydralazine can cause drug-induced lupus-like syndrome, especially in slow acetylators on higher doses 7
  • Avoid abrupt discontinuation after prolonged use 7
  • Regularly assess blood pressure response and adjust dosing accordingly 1

Pediatric Dosing

  • Safety and effectiveness in pediatric patients have not been established in controlled clinical trials 1
  • If needed in pediatric patients, the usual recommended oral starting dosage is 0.75 mg/kg daily in four divided doses, with gradual increase over 3-4 weeks to a maximum of 7.5 mg/kg or 200 mg daily 1

References

Research

Duration of hydralazine action in hypertension.

Clinical pharmacology and therapeutics, 1975

Research

Hydralazine once daily in hypertension.

British medical journal (Clinical research ed.), 1982

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.